This inventor holds 1 USPTO granted patent. Top assignee: Immunic Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Manfred GRÖPPEL: Inventor in Inflammatory and Autoimmune Disease Research
Introduction
Manfred GRÖPPEL is an inventor based in Munich, Germany, associated with Immunic AG. His patent work concerns a compound and dosage regimen intended for the prevention or treatment of chronic inflammatory and autoimmune diseases.
Latest Patents
The provided information lists 1 patent for Manfred GRÖPPEL: “Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases.” The invention describes a compound of formula (I), 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid, and a dosage regimen for its use. The compound inhibits dihydroorotate dehydrogenase (DHODH), an enzyme relevant to certain chronic inflammatory and autoimmune diseases.
Career Highlights
GRÖPPEL’s listed patent reflects work on therapeutic approaches that target DHODH. The invention focuses on the compound’s potential use in preventing or treating diseases where DHODH inhibition may offer a therapeutic advantage.
Collaborations
GRÖPPEL is associated with Immunic AG. His listed coworkers include Daniel Vitt and Hella Kohlhof.
Conclusion
Manfred GRÖPPEL’s documented invention centers on a DHODH-inhibiting compound and dosage regimen for chronic inflammatory and autoimmune diseases, reflecting his connection to therapeutic innovation at Immunic AG.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile